Literature DB >> 25653995

Arnold Chiari malformation with spina bifida: a lost opportunity of folic Acid supplementation.

Deepa Ganesh1, Benjamin M Sagayaraj2, Ravi Kumar Barua3, Nidhi Sharma4, Upasana Ranga5.   

Abstract

In Arnold Chiari (kee-AHR-ee) II malformation elongated cerebellar tonsils are displaced inferiorly through the Foramen Magnum into the upper cervical spinal canal. It is a complex anomaly with skull, dura, brain, spine and cord manifestations. Meningomyelocele is seen in all cases. We present a case of type II Arnold Chiari Malformation diagnosed in utero in a pregnant lady .There was no periconceptional folic acid supplementation. As the role of the Methylene Tetra Hydro Folate Reductase gene polymorphism in neural tube defects is becoming evident, a simple opportunity as folic acid supplementation should not be missed. Folate supplementation as fortification of cereal grains will also prevent other conditions like congenital heart defects, urinary tract anomalies, orofacial defects, limb defects and pyloric stenosis.

Entities:  

Keywords:  Arnold chiari; Folic acid; Periconception; Pregnancy

Year:  2014        PMID: 25653995      PMCID: PMC4316301          DOI: 10.7860/JCDR/2014/11242.5335

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  12 in total

1.  Folic acid: the opportunity that still exists; [comment].

Authors:  J G Hall
Journal:  CMAJ       Date:  2000-05-30       Impact factor: 8.262

2.  Hans Chiari (1851-1916).

Authors:  R Shane Tubbs; Aaron A Cohen-Gadol
Journal:  J Neurol       Date:  2010-03-26       Impact factor: 4.849

3.  Unusual association of Arnold-Chiari malformation and vitamin B12 deficiency.

Authors:  Rajesh Verma; Heramba Narayan Praharaj
Journal:  BMJ Case Rep       Date:  2012-07-09

4.  Fetal surgery: the ochsner experience with in utero spina bifida repair.

Authors:  Lora Kahn; Nnenna Mbabuike; Edison P Valle-Giler; Juanita Garces; R Clifton Moore; Hugo St Hilaire; Cuong J Bui
Journal:  Ochsner J       Date:  2014

Review 5.  [Differences in folic-acid policy and the prevalence of neural-tube defects in Europe; recommendations for food fortification in a EUROCAT report].

Authors:  W M Meijer; H E K de Walle
Journal:  Ned Tijdschr Geneeskd       Date:  2005-11-12

6.  Chiari I malformations: clinical and radiologic reappraisal.

Authors:  A D Elster; M Y Chen
Journal:  Radiology       Date:  1992-05       Impact factor: 11.105

7.  Incidence of open neural tube defects in Nova Scotia after folic acid fortification.

Authors:  Vidia L Persad; Michiel C Van den Hof; Johanne M Dubé; Pamela Zimmer
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

8.  Decline of neural tube defects cases after a folic acid campaign in Nuevo León, México.

Authors:  Laura Martínez de Villarreal; Jesús Z Villarreal Pérez; Patricia Arredondo Vázquez; Ricardo Hernández Herrera; Ma Del Roble Velazco Campos; Roberto Ambriz López; José Luis Herrera Ramírez; Jesús Manuel Yañez Sánchez; Juan José Morales Villarreal; Manuel Treviño Garza; Adriana Limón; Abel Guzmán López; Mario Bárcenas; Juan Ramón Cepeda García; Andrés Sánchez Domínguez; Rogelio Hernández Nuñez; Jorge Luis García Ayala; Jorge Garza Martínez; Mario Tijerina González; Carlos García Alvarez; Roberto Negrete Castro
Journal:  Teratology       Date:  2002-11

9.  Knowledge of periconceptional folic acid for the prevention of neural tube defects. The missing links. Northeastern Ontario Primary Care Research Group.

Authors:  M M Bonin; J A Bretzlaff; S A Therrien; B H Rowe
Journal:  Arch Fam Med       Date:  1998 Sep-Oct

10.  Association of neural tube defects and folic acid food fortification in Canada.

Authors:  Joel G Ray; Chris Meier; Marian J Vermeulen; Sheila Boss; Philip R Wyatt; David E C Cole
Journal:  Lancet       Date:  2002 Dec 21-28       Impact factor: 79.321

View more
  1 in total

1.  A case report of Arnold Chiari type 1 malformation in acromesomelic dwarf infant.

Authors:  Miteshkumar Rajaram Maurya; Renju Ravi; Sona Ajit Pungavkar
Journal:  Pan Afr Med J       Date:  2021-01-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.